Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Alnylam Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Alnylam Pharmaceuticals Inc, Medical Equipment, Deal Details 11
Arrowhead Research Enters Into Licensing Agreement With Alnylam Pharma 11
Equity Offering 12
Alnylam Pharma Raises USD805 Million in Public Offering of Shares 12
Alnylam Pharma Raises USD359.4 Million in Public Offering of Shares 14
Alnylam Pharma Raises USD518 Million in Public Offering of Shares 16
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares 18
Alnylam Pharma Completes Public Offering Of Shares For US$185 Million 19
Alnylam Pharma Completes Public Offering Of Shares For US$93 Million 20
Alnylam Pharmaceuticals Inc – Key Competitors 22
Alnylam Pharmaceuticals Inc – Key Employees 23
Alnylam Pharmaceuticals Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 25
Recent Developments 26
Financial Announcements 26
Aug 02, 2018: Alnylam Pharmaceuticals reports second quarter 2018 financial results and highlights recent period activity 26
May 03, 2018: Alnylam Pharmaceuticals Reports First Quarter 2018 Financial Results and Highlights Recent Period Activity 30
Feb 08, 2018: Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Period Activity 33
Aug 09, 2017: Alnylam Pharmaceuticals Reports Second Quarter 2017 Financial Results and Highlights Recent Period Activity 36
May 05, 2017: Alnylam Pharmaceuticals Reports First Quarter 2017 Financial Results and Highlights Recent Period Activity 38
Feb 08, 2017: Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Recent Period Activity 40
Corporate Communications 43
Oct 10, 2018: Alnylam appoints Dr. Margaret Hamburg to Board of Directors 43
Jun 20, 2018: Alnylam Pharmaceuticals Announces Senior Management Changes 44
May 15, 2018: Alnylam Appoints Colleen Reitan to the Board of Directors 45
Jun 19, 2017: Alnylam CEO, John Maraganore, Named BIO Chair for 2017-2018 Term 46
May 09, 2017: Alnylam Expands Leadership Team with Multiple Experienced Biotech Leaders 47
Jan 03, 2017: Alnylam Announces Management Change and Key Promotion 49
Legal and Regulatory 50
Oct 03, 2018: Kessler Topaz Meltzer & Check: securities fraud class action filed Against Alnylam Pharmaceuticals 50
Apr 20, 2018: Dicerna Pharmaceuticals Announces Settlement of All Litigation with Alnylam 51
Jul 03, 2017: Silence Therapeutics: Issue of claim in the UK High Courts 52
Product News 53
Oct 11, 2018: US Patent Trial & Appeal Board (PTAB) Upholds Silence Patent by Denying First of Five Patent Grant Review Applications Filed by Alnylam 53
Jun 12, 2017: Alnylam Significantly Expands Patent Portfolio with New Allowances from United States Patent and Trademark Office 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
Alnylam Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Alnylam Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Alnylam Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 9
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Arrowhead Research Enters Into Licensing Agreement With Alnylam Pharma 11
Alnylam Pharma Raises USD805 Million in Public Offering of Shares 12
Alnylam Pharma Raises USD359.4 Million in Public Offering of Shares 14
Alnylam Pharma Raises USD518 Million in Public Offering of Shares 16
Alnylam Pharma Raises USD70.7 Million in Private Placement of Shares 18
Alnylam Pharma Completes Public Offering Of Shares For US$185 Million 19
Alnylam Pharma Completes Public Offering Of Shares For US$93 Million 20
Alnylam Pharmaceuticals Inc, Key Competitors 22
Alnylam Pharmaceuticals Inc, Key Employees 23
Alnylam Pharmaceuticals Inc, Subsidiaries 24
Alnylam Pharmaceuticals Inc, Joint Venture 25
List of Figures
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Alnylam Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer